PNEUMOCYSTIS JIROVECI PNEUMONIA
Clinical trials for PNEUMOCYSTIS JIROVECI PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS JIROVECI PNEUMONIA trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECI PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could shorter steroid courses be safer for severe pneumonia patients?
Disease control Not yet recruitingThis study looks at how long steroids should be given to adults with a severe type of pneumonia (PCP) who have weak immune systems. Patients who get better quickly are split into two groups: one stops steroids after 10 days, the other continues for 21 days. The goal is to see if …
Matched conditions: PNEUMOCYSTIS JIROVECI PNEUMONIA
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 17, 2026 05:04 UTC
-
Could steroids slash death rates from a rare, deadly pneumonia?
Disease control Not yet recruitingThis study tests whether adding corticosteroids to standard care can lower the high death rate (60-80%) of a severe lung infection called PJP in people with weakened immune systems who are not HIV-positive. About 240 adults in intensive care will receive different doses of steroi…
Matched conditions: PNEUMOCYSTIS JIROVECI PNEUMONIA
Phase: PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated May 11, 2026 20:50 UTC